Current progress on development of respiratory syncytial virus vaccine

Pharmacology, Toxicology and Pharmaceutical Science

• Respiratory Syncytial Virus Vaccine 100%
• Disease 100%
• Viral Protein 50%
• Respiratory Tract 50%
• Infectious Agent 50%
• Formaldehyde 50%
• Infection 50%
• Lung Disease 50%
• Respiratory Syncytial Virus Infection 50%
• Reinfection 50%
• Maternal Antibody 50%
• Human Respiratory Syncytial Virus 50%

Immunology and Microbiology

• Respiratory Syncytial Virus 100%
• Respiratory Syncytial Virus Vaccine 100%
• Human Respiratory Syncytial Virus 33%
• Respiratory Syncytial Virus Infection 16%
• Upper Respiratory Tract 16%
• Maternal Antibody 16%
• Infectious Agent 16%
• Immune Response 16%
• Immune System 16%
• Virus Attenuation 16%
• Lower Respiratory Tract 16%
• Protein Subunit 16%
• Virus Inactivation 16%
• Viral Protein 16%

Biochemistry, Genetics and Molecular Biology

• Human Respiratory Syncytial Virus 100%
• Virus Inactivation 33%
• Virus Attenuation 33%
• Infectious Agent 33%
• Immunity 33%
• Immune Response 33%
• Viral Protein 33%
• Protein Subunit 33%